▲ BUY
10
/ 10
Conviction
$ Value
$25K
Shares
29,500
Price
$1
Filed
Feb 13
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Cluster: 9 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Kelly Jared
Title
Chief Executive Officer
CIK
0002103581
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-12
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
109,000
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.820 to $0.856, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Filing Info
Kelly Jared's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-12 | ONCY | ▲ | $5K |
| 2026-02-12 | ONCY | ▲ | $25K ★ |
| 2026-02-11 | ONCY | ▲ | $5K |
Other Insiders at ONCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Seizinger Bernd R. | $83K | — | 2026-02-12 |
| Andrews Patricia S | $30K | — | 2026-02-12 |
|
Aromando Andrew
Chief Business Officer
|
$25K | — | 2026-02-11 |
| Pisano Wayne | $25K | — | 2026-02-12 |
| Brown Deborah Margaret | $21K | — | 2026-02-12 |
| Parsons James T. | $10K | — | 2026-03-11 |
|
Look Kirk
Chief Financial Officer
|
$10K | — | 2026-02-12 |
|
Heineman Thomas Charles
Chief Medical Officer
|
$10K | — | 2026-02-12 |
|
Kelly Jared
Chief Executive Officer
|
$10K | — | 2026-03-12 |
|
Hagerman Allison
VP, Product Development
|
$8K | — | 2026-02-12 |